Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03581682 · ClinicalTrials.gov registry record · NA
Tele-Clinic Visits in Pediatric Marfan Patients Using Parental Echo: The Future?
A NA study, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT03581682: Completed NA study, sponsored by Stanford University.
NCT03581682 is a NA study that has completed, run by Stanford University. The registered enrollment target is 15 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03581682, a NA study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Marfan syndrome (MFS), a connective tissue disorder seen in 1 in 3,000 individuals, causes progressive aortic root dilation that can result in aortic dissection and sudden death. Clinical care focuses on monitoring the aortic root by serial echocardiography (echo) to guide medical treatment and elective aortic root surgery in a specialized clinic every 6-12 months. This monitoring protocol, coupled with surgical intervention, has doubled the median life expectancy which was previously only 32 years. However, this surveillance carries significant health care costs at \>$50 million dollars/year on echos alone (at $3-4K each) in children and adolescents in the US, as well as substantial burden on families residing far from specialized centers. A clinic visit delivered to MFS patients via live-video conferencing at home (tele-visit) could shift this paradigm, if a home echo could be obtained. Here, the investigator will train parents of Pediatric Marfan patients to take echo images using a hand held device, height, weight, blood pressure, medical history, and listen to the heart of their child. Then, the investigators will ask them to take the equipment home and collect the same data at home during a tele-clinic visit, with further instruction by the study team through secure live-video conferencing.
Interventions
- OTHER Tele-Clinic Visits Using Parent-Acquired Echos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2018-07-01 |
| Est. Completion | 2020-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03581682
The ClinicalTrials.gov registry entry for NCT03581682 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Tele-Clinic Visits Using Parent-Acquired Echos is the first listed.
NCT03581682 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03581682 about?
NCT03581682 is a clinical study titled "Tele-Clinic Visits in Pediatric Marfan Patients Using Parental Echo: The Future?". Marfan syndrome (MFS), a connective tissue disorder seen in 1 in 3,000 individuals, causes progressive aortic root dilation that can result in aortic dissection and sudden death. Clinical care focuses on monitoring the aortic root by serial echocardiography (echo) to guide medical treatment and elec...
What is the current status of trial NCT03581682?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2018-07-01. Estimated completion is 2020-08-01.
What interventions are being tested in trial NCT03581682?
The interventions under investigation include: Tele-Clinic Visits Using Parent-Acquired Echos (OTHER).
Who is sponsoring clinical trial NCT03581682?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.